lead position
Sponsored content
Sponsored by
Henry Goh & Co
Features list
-
Welcome to the eighth edition of Managing IP's India Focus. We have a diverse selection of articles this year that shows the wide range of issues facing India's IP system. These vary from questions over software patents and the patentability of pharmaceutical products to missing files at the trade mark office and accession to the Madrid Protocol. As this supplement goes to press, a key case dealing with the patentability of Novartis's anti-cancer drug Glivec is being argued at the Supreme Court. Patent practitioners are hoping the judgment may finally shed some light on the notorious Section 3(d) of the country's Patent Act. And in the Monsoon session of Parliament India's politicians may pass far-reaching amendments to the country's Copyright Act.
-
Prietika Siingh and Dheeraj Seth of Inttl Advocare present an overview of the progress that has been made in protecting traditional knowledge and geographical indications in India
-
Akihiro Ryuka and Stephen Hamon of Ryuka IP Law Firm present a strategy for obtaining strong IP rights in the electronics and software fields
-
Jakkrit Kuanpoth of Tilleke & Gibbins looks at the ins and outs of the Free Trade Agreement that will bring Australia and New Zealand closer to their developing neighbours
-
Prem N Sewak and Shefali Sewak of Sewak & Associates look at the factors involved in how well-known brands are protected against infringement
-
Victor Lee, Crystal Chen and Iris Lin of Tsai Lee & Chen explain how an extraordinarily large damages award to Hermès sparked reform of the law on trade mark infringement
Local Insights